Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. FDX
5. IBM
6. MU
7. META
8. USO
9. NVDA
10. BLZE

Go back to Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 13.60 -0.11 (0.8%)
Previous Close $13.71    52 Week High $5.58 
Open $13.51    52 Week Low $3.60 
Day High $13.62    P/E N/A 
Day Low $13.48    EPS $0.00 
Volume 7,047,567       

SANOFI (NASDAQ: SNY) Delayed: 41.60 -0.18 (0.43%)
Previous Close $41.78    52 Week High $44.76 
Open $42.27    52 Week Low $36.81 
Day High $42.47    P/E N/A 
Day Low $41.47    EPS $0.00 
Volume 10,855,464